Recommendations for Prevention of HIV Transmission in Health-Care Settings

CDC. Acquired immunodeficiency syndrome (AIDS): Precautions for clinical and laboratory staffs. MMWR 1982;31:577-80.

CDC. Acquired immunodeficiency syndrome (AIDS): Precautions for health-care workers and allied professionals. MMWR 1983;32:450-1.

CDC. Recommendations for preventing transmission of infection with human T-lymphotropic virus type Illlymphadenopathy-associated virus in the workplace. MMWR 1985;34:681-6, 691-5.

CDC. Recommendations for preventing transmission of infection with human T-lymphotropic virus type Illymphadenopathy-associated virus during invasive proce- dures. MMWR 1986;35:221-3.

CDC. Recommendations for preventing possible transmission of human T-lymphotropic virus type Illlymphadenopathy-associated virus from tears. MMMWR 1985;34:533-4.

CDC. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type Illymphadenopathy-associated virus infection. MMMMWR 1986;35:376-8, 383.

Garner JS, Simmons BP. Guideline for isolation precautions in hospitals. Infect Control 1983;4 (suppl) :245-325.

CDC. Recommended infection control practices for dentistry. MMWWR 1986:35:237-42.

McCray E, The Cooperative Needlestick Surveillance Group. Occupational risk of the acquired immunodeficiency syndrome among health care workers. N Eng! J Med 1986;314:1127-32.

Henderson DK, Saah AJ, Zak BJ, et al. Risk of nosocomial infection with human T-cell lymphotropic virus type IlI/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med 1986;104:644-7.

Gerberding JL, Bryant-LeBlanc CE, Nelson K, et al. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis 1987;156:1-8.

McEvoy M, Porter K, Mortimer P, Simmons N, Shanson D. Prospective study of clical, laboratory, and ancillary staff with accidental exposures to blood or other body fluids from patients infected with HIV. Br Med J 1987;294:1595-7.

Anonymous. Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet 1984;2:1376-7.

Oksenhendler E, Harzic M, Le Roux JM, Rabian C, Clauvel JP. HIV infection with serocon- version after a superficial needlestick injury to the finger. N Engl J Med 1986;315:582.

Neisson-Vernant C, Arfi S, Mathez D, Leibowitch J, Monplaisir N. Needlestick HIV serocon- version in a nurse. Lancet 1986;2:814.

Grint P, McEvoy M. Two associated cases of the acquired immune deficiency syndrome (AIDS). PHLS Commun Dis Rep 1985;42:4.

CDC. Apparent transmission of human T-lymphotropic virus type Ill/ymphadenopathy-associated virus from a child to a mother providing health care. MMWWR 1986;35:76-9.

CDC. Update: Human immunodeficiency virus infections in health-care workers exposed to blood of infected patients. MMWR 1987;36:285-9.

Kline RS, Phelan J, Friedland GH, et al. Low occupational risk for HIV infection for dental professionals [Abstract]. In: Abstracts from the III International Conference on AIDS, 1-5 June 1985. Washington, DC: 155.

Baker JL, Kelen GD, Sivertson KT, Quinn TC. Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA 1987;257:2609-11.

Favero MS. Dialysis-associated diseases and their control. In: Bennett JV, Brachman PS, eds. Hospital infections. Boston: Little, Brown and Company, 1985:267-84.

Richardson JH, Barkley WE, eds. Biosafety in microbiological and biomedical laboratories, 1984. Washington, DC : US Department of Health and Human Services, Public Health Service. HHS publication no. (CDC) 84-8395.

CDC. Human T-lymphotropic virus type Illymphadenopathy-associated virus: Agent summary statement. MMWR 1986;35:540-2,547-7-9.

Environmental Protection Agency. EPA guide for infectious waste management. Washington, DC:U.S. Environmental Protection Agency, May 1986 (Publication no. EPA/530-SW-86-014).

Favero MS. Sterilization, disinfection, and antisepsis in the hospital. In: Manu microbiology. 4th ed. Washington, DC: American Society for Microbiology, 1985;129-37.

Garner JS, Favero MS. Guideline for handwashing and hospital environmetal control, 1985. Atlanta: Public Health Service, Centers for Disease Control, 1985. HHS publication no. 99-1117.

Spire B, Montagnier L, Barre-Sinoussi F, Chermann JC. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet 1984;2:899-901.

Martin LS, McDougal JS, Loskoski SL. Disinfection and inactivation of the human T lymphotropic virus type Illymphadenopathy-associated virus. J Infect Dis 1985; 152:400-3.

McDougal JS, Martin LS, Cort SP, et al. Thermal inactivation of the acquired immunodeficiency syndrome virus-Illlymphadenopathy-associated virus, with special reference to antihemophilic factor. J Clin Invest 1985;76:875-7.

Spire B, Barre-Sinoussi F, Dormont D, Montagnier L, Chermann JC. Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet 1985;1:188-9.

Resnik L, Veren K, Salahuddin SZ, Tondreau S, Markham PD. Stability and inactivation of HTLV-IIILAV under clinical and laboratory environments. JAMA 1986;2555:1887-91.

CDC. Public Health Service (PHS) guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMMWR 1987;3:509-15.

Kane MA, Lettau LA. Transmission of HBV from dental personnel to patients. J Am Dent

Assoc 1985;110:634-6.

Lettau LA, Smith JD, Wiliams D, et. al. Transmission of hepatitis B with resultant restriction of surgical practice. JAMA 1986;255:934-7.

Williams WW. Guideline for infection control in hospital personnel. Infect Control 1983;4 (suppl) :326-49.

CDC. Prevention of acquired immune deficiency syndrome (AIDS): Report of inter-a recommendations. MMWR 1983;32:101-3.

CDC. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR 1985;34:1-5.